Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)
China flag China · Delayed Price · Currency is CNY
3.250
+0.030 (0.93%)
Sep 2, 2026, 3:00 PM CST

SHA:603718 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-325.65-311.44171.1862.87121.6153.86
Depreciation & Amortization
21.1517.7837.4239.7147.3757.57
Other Amortization
3.522.111.841.162.273.9
Loss (Gain) From Sale of Assets
-0.16-0.34--0.610.36-7.41
Asset Writedown & Restructuring Costs
641.64638.081.890.050.14-
Loss (Gain) From Sale of Investments
-5.62-4.59-145.64-56.62-11.44-35.89
Provision & Write-off of Bad Debts
0.710.713.541.03-0.434.95
Other Operating Activities
24.8422.898.56-4.17-0.5310.43
Change in Accounts Receivable
3.1316.27-19.4154.9224.66-68.69
Change in Inventory
-2.13-4.149.175.76-3.79-30.32
Change in Accounts Payable
-18.65-17.01-59.21-129.71117.4354.76
Change in Other Net Operating Assets
-396.65-399.320.4523.29--
Operating Cash Flow
43.2658.8346.47-8.37292.9143.63
Operating Cash Flow Growth
-40.68%26.60%--571.29%-73.98%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-10.19-12.17-8.39-7.81-19.85-37.78
Sale of Property, Plant & Equipment
0.330.58-0.080.1528.21
Cash Acquisitions
-128.65-21.51-768.33-2.29--31.5
Divestitures
---9.83110.98--
Investment in Securities
-55.46-69.26625.23-277.4974.6263.99
Other Investing Activities
53.951.1199.665.4311.218.62
Investing Cash Flow
-140.06-51.2638.34-171.0966.1341.54

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-3837.992002018
Total Debt Issued
703837.992002018
Short-Term Debt Repaid
---688.41-66.48-368.32-23.81
Long-Term Debt Repaid
--32.73-1.71-2.07-6.53-1.2
Total Debt Repaid
-45.58-32.73-690.13-68.55-374.85-25.01
Net Debt Issued (Repaid)
24.42-29.73147.86131.45-354.85-7.01
Issuance of Common Stock
---66.44--
Common Dividends Paid
-122.88-122.26-21.57-37.9-0.68-2.98
Other Financing Activities
-5.23----60
Financing Cash Flow
-103.7-151.99126.29159.99-355.5350.01

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-2.99-2.4310.300.01-0
Net Cash Flow
-203.49-146.84221.41-19.463.52135.18

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
33.0746.6638.08-16.18273.065.85
Free Cash Flow Growth
-48.44%22.53%--4564.07%-95.62%
Free Cash Flow Margin
15.46%24.84%14.05%-6.72%91.02%1.69%
Free Cash Flow Per Share
0.050.070.06-0.030.430.01
Levered Free Cash Flow
68.6447.6144.6880.42180.23-163.6
Unlevered Free Cash Flow
69.4348.448.1183.79186.68-155.87

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
34.4437.4323.8957.716.1928.94
Change in Working Capital
-317.16-306.38-32.33-51.78133.55-43.76